XNAS 27 Jun, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Vong John | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2023 | 1,813 | 10,340 (0%) | 0% | 0 | Common Stock | |
| Schmidt David G. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2023 | 5,750 | 5,750 (0%) | 0% | 0 | Common Stock | |
| Kenneth Sim | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2023 | 30,000 | 351,859 (0%) | 0% | 0 | Common Stock | |
| Vong John | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2023 | 7,100 | 19,253 (0%) | 0% | 0 | Common Stock | |
| Vong John | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2023 | 1,813 | 8,527 (0%) | 0% | 0 | Common Stock | |
| Lam S. Thomas | Director, President and Co-CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2023 | 30,000 | 321,855 (0%) | 0% | 0 | Common Stock | |
| Mitchell Kitayama W. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2023 | 6,750 | 6,750 (0%) | 0% | 0 | Common Stock | |
| S. Lam Thomas | Director, President and Co-CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2023 | 30,000 | 381,855 (0%) | 0% | 0 | Common Stock | |
| Kenneth Sim | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2023 | 30,000 | 381,859 (0%) | 0% | 0 | Common Stock | |
| Matthew Mazdyasni | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2023 | 4,750 | 4,750 (0%) | 0% | 0 | Common Stock | |
| Vong John | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2023 | 1,813 | 6,714 (0%) | 0% | 0 | Common Stock | |
| John Vong | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2023 | 1,813 | 12,153 (0%) | 0% | 0 | Common Stock | |
| Chiang John | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2023 | 4,750 | 4,850 (0%) | 0% | 0 | Common Stock | |
| Sim Kenneth | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2023 | 30,000 | 321,859 (0%) | 0% | 0 | Common Stock | |
| Weili Dai | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2023 | 3,650 | 3,650 (0%) | 0% | 0 | Common Stock | |
| Thomas Lam S. | Director, President and Co-CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2023 | 30,000 | 351,855 (0%) | 0% | 0 | Common Stock | |
| Linda Marsh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2023 | 3,650 | 66,150 (0%) | 0% | 0 | Common Stock | |
| David Schmidt G. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.11 per share. | 06 Dec 2023 | 7,500 | 7,500 (0%) | 0% | 18.1 | 135,825 | Common Stock |
| David G. Schmidt | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2023 | 7,500 | 0 | - | - | Stock Option (right to buy) | |
| Schmidt David G. | Director | Sale or transfer of securities back to the company at price $ 33.49 per share. | 06 Dec 2023 | 7,500 | 0 (0%) | 0% | 33.5 | 251,175 | Common Stock |
| W. Kitayama Mitchell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.11 per share. | 06 Dec 2023 | 7,500 | 7,500 (0%) | 0% | 18.1 | 135,825 | Common Stock |
| Kitayama Mitchell W. | Director | Sale or transfer of securities back to the company at price $ 33.49 per share. | 06 Dec 2023 | 7,500 | 0 (0%) | 0% | 33.5 | 251,175 | Common Stock |
| Kitayama W. Mitchell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2023 | 7,500 | 0 | - | - | Stock Option (right to buy) | |
| John Vong | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.23 per share. | 30 Nov 2023 | 65 | 4,901 (0%) | 0% | 33.2 | 2,160 | Common Stock |
| Brandon Sim | Co-Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2023 | 380,053 | 902,620 (1%) | 0% | 0 | Common Stock | |
| Chandan Basho | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2023 | 130,732 | 207,671 (0%) | 0% | 0 | Common Stock | |
| Linda Marsh | Director | Sale or transfer of securities back to the company at price $ 35.32 per share. | 14 Mar 2023 | 270,081 | 0 (0%) | 0% | 35.3 | 9,539,261 | Common Stock |
| John Vong | SVP-Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2022 | 1,388 | 5,159 (0%) | 0% | 0 | Common Stock | |
| John Vong | SVP-Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2022 | 694 | 7,935 (0%) | 0% | 0 | Common Stock | |
| John Vong | SVP-Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2022 | 694 | 7,241 (0%) | 0% | 0 | Common Stock | |
| John Vong | SVP-Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2022 | 1,388 | 6,547 (0%) | 0% | 0 | Common Stock | |
| Kenneth Sim | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.00 per share. | 08 Dec 2022 | 48,587 | 291,859 (0%) | 0% | 11 | 534,457 | Common Stock |
| Kenneth Sim | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.00 per share. | 08 Dec 2022 | 51,445 | 243,272 (0%) | 0% | 10 | 514,450 | Common Stock |
| Kenneth Sim | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2022 | 48,587 | 0 | - | - | Warrants to purchase Common Stock | |
| Kenneth Sim | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2022 | 51,445 | 0 | - | - | Warrants to purchase Common Stock | |
| Thomas S. Lam | Director, President and Co-CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Dec 2022 | 51,442 | 0 | - | - | Warrants to purchase Common Stock | |
| Thomas S. Lam | Director, President and Co-CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.00 per share. | 05 Dec 2022 | 51,443 | 243,270 (0%) | 0% | 10 | 514,430 | Common Stock |
| Thomas S. Lam | Director, President and Co-CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.00 per share. | 05 Dec 2022 | 48,585 | 291,855 (0%) | 0% | 11 | 534,435 | Common Stock |
| Thomas S. Lam | Director, President and Co-CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Dec 2022 | 48,585 | 0 | - | - | Warrants to purchase Common Stock | |
| Thomas S. Lam | Director, President and Co-CEO | Other type of transaction at price $ 0.00 per share. | 02 Dec 2022 | 984,042 | 10,191,660 (19%) | 1% | 0 | Common Stock | |
| Thomas S. Lam | Director, President and Co-CEO | Other type of transaction at price $ 0.00 per share. | 02 Dec 2022 | 37,439 | 1,107,474 (2%) | 0% | 0 | Common Stock | |
| Kenneth Sim | Director, Executive Chairman | Other type of transaction at price $ 0.00 per share. | 02 Dec 2022 | 984,042 | 10,191,660 (19%) | 1% | 0 | Common Stock | |
| Kenneth Sim | Director, Executive Chairman | Other type of transaction at price $ 0.00 per share. | 02 Dec 2022 | 37,439 | 520,117 (0%) | 0% | 0 | Common Stock | |
| Albert Young | Chief Administrative Officer | Other type of transaction at price $ 0.00 per share. | 02 Dec 2022 | 984,042 | 10,191,660 (19%) | 1% | 0 | Common Stock | |
| Albert Young | Chief Administrative Officer | Other type of transaction at price $ 0.00 per share. | 02 Dec 2022 | 19,506 | 1,184,749 (2%) | 0% | 0 | Common Stock | |
| Albert Young | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.00 per share. | 29 Nov 2022 | 26,828 | 1,165,243 (2%) | 0% | 11 | 295,108 | Common Stock |
| Albert Young | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Nov 2022 | 28,406 | 0 | - | - | Warrants to purchase Common Stock | |
| Albert Young | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Nov 2022 | 26,828 | 0 | - | - | Warrants to purchase Common Stock | |
| Albert Young | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.00 per share. | 29 Nov 2022 | 28,406 | 1,138,415 (2%) | 0% | 10 | 284,060 | Common Stock |
| Brandon Sim | Co- Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2022 | 198,511 | 491,134 (0%) | 0% | 0 | Common Stock | |
| Brandon Sim | Co- Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2022 | 108,560 | 292,623 (0%) | 0% | 0 | Common Stock | |
| Albert Young | Chief Administrative Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 48.47 per share. | 31 Mar 2022 | 256 | 1,110,009 (2%) | 0% | 48.5 | 12,408 | Common Stock |
| Eric Chin | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 48.47 per share. | 31 Mar 2022 | 469 | 20,844 (0%) | 0% | 48.5 | 22,732 | Common Stock |
| Thomas S. Lam | Director, President and Co-CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Mar 2022 | 200,000 | 799,855 (1%) | 0% | 0 | Common Stock | |
| Thomas S. Lam | Director, President and Co-CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Mar 2022 | 383,764 | 0 (0%) | 0% | 0 | Common Stock | |
| Thomas S. Lam | Director, President and Co-CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Mar 2022 | 383,764 | 0 (0%) | 0% | 0 | Common Stock | |
| Kenneth Sim | Director, Executive Chairman | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Feb 2022 | 392,816 | 0 (0%) | 0% | 0 | Common Stock | |
| Kenneth Sim | Director, Executive Chairman | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Feb 2022 | 258,824 | 230,576 (0%) | 0% | 0 | Common Stock | |
| Kenneth Sim | Director, Executive Chairman | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Feb 2022 | 392,816 | 0 (0%) | 0% | 0 | Common Stock | |
| Brandon Sim | Co-CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Feb 2022 | 392,816 | 392,816 (0%) | 0% | 0 | Common Stock | |
| Brandon Sim | Co-CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Feb 2022 | 258,824 | 258,824 (0%) | 0% | 0 | Common Stock | |
| Eric Chin | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.71 per share. | 03 Feb 2022 | 2,802 | 21,313 (0%) | 0% | 50.7 | 142,089 | Common Stock |
| Mitchell W. Kitayama | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2022 | 8,500 | 8,500 | - | - | Stock Option (right to buy) | |
| Ernest A. Bates | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2022 | 8,500 | 8,500 | - | - | Stock Option (right to buy) | |
| David G. Schmidt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2022 | 8,500 | 8,500 | - | - | Stock Option (right to buy) | |
| Mark Fawcett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2022 | 8,500 | 8,500 | - | - | Stock Option (right to buy) | |
| Michael F. Eng | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2022 | 8,500 | 8,500 | - | - | Stock Option (right to buy) | |
| Linda Marsh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2022 | 8,500 | 8,500 | - | - | Stock Option (right to buy) | |
| John Chiang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2022 | 8,500 | 8,500 | - | - | Stock Option (right to buy) | |
| Matthew Mazdyasni | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2022 | 8,500 | 8,500 | - | - | Stock Option (right to buy) | |
| Kenneth Sim | Director, Executive Chairman | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Nov 2021 | 230,688 | 397,724 (0%) | 0% | 0 | Common Stock | |
| Thomas S. Lam | Director, President and Co-CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2021 | 29,502 | 29,502 | - | - | Stock Option (right to buy) | |
| Thomas S. Lam | Director, President and Co-CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2021 | 65,242 | 191,827 (0%) | 0% | 0 | Common Stock | |
| Kenneth Sim | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2021 | 65,242 | 191,827 (0%) | 0% | 0 | Common Stock | |
| Kenneth Sim | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2021 | 29,502 | 29,502 | - | - | Stock Option (right to buy) | |
| Brandon Sim | Co-CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2021 | 54,486 | 54,486 | - | - | Stock Option (right to buy) | |
| Brandon Sim | Co-CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2021 | 42,451 | 184,063 (0%) | 0% | 0 | Common Stock | |
| David G. Schmidt | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.20 per share. | 17 Aug 2021 | 40,000 | 40,000 (0%) | 0% | 5.2 | 208,000 | Common Stock |
| David G. Schmidt | Director | Sale of securities on an exchange or to another person at price $ 73.67 per share. | 17 Aug 2021 | 40,000 | 0 (0%) | 0% | 73.7 | 2,946,800 | Common Stock |
| David G. Schmidt | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Aug 2021 | 40,000 | 0 | - | - | Stock Option (right to buy) | |
| Albert Young | Chief Administrative Officer | Sale of securities on an exchange or to another person at price $ 48.58 per share. | 15 Jun 2021 | 5,000 | 1,110,265 (2%) | 0% | 48.6 | 242,900 | Common Stock |
| Brandon Sim | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.88 per share. | 31 May 2021 | 5,426 | 141,612 (0%) | 0% | 34.9 | 189,259 | Common Stock |
| Brandon Sim | See Remarks | Purchase of securities on an exchange or from another person at price $ 31.40 per share. | 13 May 2021 | 1,000 | 147,038 (0%) | 0% | 31.4 | 31,400 | Common Stock |
| Adrian Vazquez | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 24.50 per share. | 28 Apr 2021 | 100,000 | 371,004 (0%) | 0% | 24.5 | 2,450,000 | Common Stock |
| Thomas S. Lam | Director, President and Co-CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.00 per share. | 30 Mar 2021 | 31,755 | 908,183 (1%) | 0% | 10 | 317,550 | Common Stock |
| Thomas S. Lam | Director, President and Co-CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Mar 2021 | 31,755 | 0 | - | - | Warrant to Purchase Common Stock | |
| Kenneth Sim | Director, Executive Chairman and Co-CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.00 per share. | 30 Mar 2021 | 31,756 | 859,101 (1%) | 0% | 10 | 317,560 | Common Stock |
| Kenneth Sim | Director, Executive Chairman and Co-CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Mar 2021 | 31,756 | 0 | - | - | Warrant to Purchase Common Stock | |
| Eric Chin | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2021 | 8,606 | 24,670 (0%) | 0% | 0 | Common Stock | |
| Brandon Sim | COO, CTO and VP of Engineering | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2021 | 59,165 | 146,038 (0%) | 0% | 0 | Common Stock | |
| Eric Chin | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 6,867 | 16,064 (0%) | 0% | 0 | Common Stock | |
| Eric Chin | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 3,103 | 3,103 | - | - | Stock Option (right to buy) | |
| Brandon Sim | COO, CTO and VP of Engineering | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 21,334 | 21,334 | - | - | Stock Option (right to buy) | |
| Brandon Sim | COO, CTO and VP of Engineering | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 47,210 | 86,873 (0%) | 0% | 0 | Common Stock | |
| Thomas S. Lam | Director, President and Co-CEO | Other type of transaction at price $ 0.00 per share. | 22 Dec 2020 | 185,938 | 876,428 (1%) | 0% | 0 | Common Stock | |
| Thomas S. Lam | Director, President and Co-CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.00 per share. | 22 Dec 2020 | 31,755 | 908,183 (1%) | 0% | 10 | 317,550 | Common Stock |
| Kenneth Sim | Director, Executive Chairman and Co-CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.00 per share. | 22 Dec 2020 | 31,756 | 859,100 (1%) | 0% | 10 | 317,560 | Common Stock |
| Kenneth Sim | Director, Executive Chairman and Co-CEO | Other type of transaction at price $ 0.00 per share. | 22 Dec 2020 | 185,938 | 827,344 (1%) | 0% | 0 | Common Stock | |
| Albert Young | Chief Administrative Officer | Other type of transaction at price $ 0.00 per share. | 22 Dec 2020 | 96,877 | 1,115,265 (2%) | 0% | 0 | Common Stock | |
| Kenneth Sim | Director, Executive Chairman and Co-CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2020 | 29,502 | 29,502 | - | - | Stock Option (right to buy) | |
| Kenneth Sim | Director, Executive Chairman and Co-CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2020 | 65,242 | 126,585 (0%) | 0% | 0 | Common Stock | |
| Mitchell W. Kitayama | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2020 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Ernest A. Bates | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2020 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Li Yu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2020 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| David G. Schmidt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2020 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Mark Fawcett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2020 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Michael F. Eng | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2020 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Linda Marsh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2020 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| John Chiang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2020 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Matthew Mazdyasni | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2020 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Thomas S. Lam | Director, President and Co-CEO | Purchase of securities on an exchange or from another person at price $ 17.28 per share. | 14 Sep 2020 | 5,000 | 690,490 (1%) | 0% | 17.3 | 86,381 | Common Stock |
| Kenneth Sim | Director, Executive Chairman and Co-CEO | Purchase of securities on an exchange or from another person at price $ 17.23 per share. | 14 Sep 2020 | 5,000 | 42,996 (0%) | 0% | 17.2 | 86,168 | Common Stock |
| Kenneth Sim | Director, Executive Chairman and Co-CEO | Purchase of securities on an exchange or from another person at price $ 17.20 per share. | 14 Sep 2020 | 1,000 | 17,379 (0%) | 0% | 17.2 | 17,204 | Common Stock |
| Brandon Sim | See Remarks | Purchase of securities on an exchange or from another person at price $ 17.20 per share. | 14 Sep 2020 | 1,000 | 17,379 (0%) | 0% | 17.2 | 17,204 | Common Stock |
| Brandon Sim | See Remarks | Purchase of securities on an exchange or from another person at price $ 17.23 per share. | 14 Sep 2020 | 5,000 | 42,996 (0%) | 0% | 17.2 | 86,168 | Common Stock |
| Adrian Vazquez | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 18.00 per share. | 11 Sep 2020 | 602 | 471,004 (0%) | 0% | 18 | 10,836 | Common Stock |
| Thomas S. Lam | Director, President and Co-CEO | Other type of transaction at price $ 0.00 per share. | 10 Sep 2020 | 564,691 | 685,490 (1%) | 1% | 0 | Common Stock | |
| Thomas S. Lam | Director, President and Co-CEO | Other type of transaction at price $ 0.00 per share. | 10 Sep 2020 | 564,691 | 564,691 (1%) | 1% | 0 | Common Stock | |
| Kenneth Sim | Director, Executive Chairman and Co-CEO | Purchase of securities on an exchange or from another person at price $ 17.60 per share. | 10 Sep 2020 | 5,000 | 37,996 (0%) | 0% | 17.6 | 88,000 | Common Stock |
| Brandon Sim | See Remarks | Purchase of securities on an exchange or from another person at price $ 17.60 per share. | 10 Sep 2020 | 5,000 | 37,996 (0%) | 0% | 17.6 | 88,000 | Common Stock |
| Kenneth Sim | Director, Executive Chairman and Co-CEO | Other type of transaction at price $ 0.00 per share. | 09 Sep 2020 | 564,706 | 641,407 (1%) | 1% | 0 | Common Stock | |
| Kenneth Sim | Director, Executive Chairman and Co-CEO | Other type of transaction at price $ 0.00 per share. | 09 Sep 2020 | 564,706 | 564,706 (1%) | 1% | 0 | Common Stock | |
| Adrian Vazquez | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 18.00 per share. | 08 Sep 2020 | 7,484 | 471,606 (0%) | 0% | 18 | 134,712 | Common Stock |
| Adrian Vazquez | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 18.15 per share. | 08 Sep 2020 | 5,783 | 479,090 (0%) | 0% | 18.1 | 104,949 | Common Stock |
| Thomas S. Lam | Director, President and Co-CEO | Purchase of securities on an exchange or from another person at price $ 17.85 per share. | 08 Sep 2020 | 5,000 | 1,814,872 (3%) | 0% | 17.9 | 89,250 | Common Stock |
| Thomas S. Lam | Director, President and Co-CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.89 per share. | 08 Sep 2020 | 30,252 | 1,809,872 (3%) | 0% | 18.9 | 571,460 | Common Stock |
| Thomas S. Lam | Director, President and Co-CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.00 per share. | 08 Sep 2020 | 63,510 | 1,840,124 (3%) | 0% | 9 | 571,590 | Common Stock |
| Thomas S. Lam | Director, President and Co-CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Sep 2020 | 63,510 | 0 | - | - | Warrants to Purchase Common Stock | |
| Thomas S. Lam | Director, President and Co-CEO | Purchase of securities on an exchange or from another person at price $ 18.23 per share. | 27 Aug 2020 | 5,000 | 1,776,614 (3%) | 0% | 18.2 | 91,150 | Common Stock |
| Kenneth Sim | Director, Executive Chairman and Co-CEO | Purchase of securities on an exchange or from another person at price $ 18.34 per share. | 27 Aug 2020 | 5,000 | 1,770,556 (3%) | 0% | 18.3 | 91,700 | Common Stock |
| Brandon Sim | See Remarks, Item 2 | Purchase of securities on an exchange or from another person at price $ 18.34 per share. | 27 Aug 2020 | 5,000 | 1,770,556 (3%) | 0% | 18.3 | 91,700 | Common Stock |
| Adrian Vazquez | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 17.23 per share. | 05 Jun 2020 | 29,185 | 489,073 (0%) | 0% | 17.2 | 502,858 | Common Stock |
| Adrian Vazquez | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 17.09 per share. | 05 Jun 2020 | 4,200 | 484,873 (0%) | 0% | 17.1 | 71,778 | Common Stock |
| Adrian Vazquez | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 18.00 per share. | 03 Jun 2020 | 2,683 | 518,258 (0%) | 0% | 18 | 48,294 | Common Stock |
| Hing Ang | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 26 May 2020 | 2,444 | 38,316 (0%) | 0% | 0 | Common Stock | |
| Mark Fawcett | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.00 per share. | 06 May 2020 | 20,000 | 30,000 (0%) | 0% | 5 | 100,000 | Common Stock |
| Mark Fawcett | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 06 May 2020 | 20,000 | 36,909 | - | - | Stock Option (right to buy) | |
| Albert Young | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.00 per share. | 31 Mar 2020 | 35,069 | 1,001,109 (1%) | 0% | 9 | 315,621 | Common Stock |
| Albert Young | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.00 per share. | 31 Mar 2020 | 17,534 | 1,018,643 (1%) | 0% | 10 | 175,340 | Common Stock |
| Albert Young | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2020 | 35,069 | 0 | - | - | Warrants to Purchase Common Stock | |
| Albert Young | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2020 | 17,534 | 0 | - | - | Warrants to Purchase Common Stock | |
| Albert Young | Chief Administrative Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.92 per share. | 31 Mar 2020 | 256 | 966,040 (1%) | 0% | 12.9 | 3,308 | Common Stock |
| Eric Chin | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 14.90 per share. | 31 Mar 2020 | 2,040 | 9,197 (0%) | 0% | 14.9 | 30,396 | Common Stock |
| Eric Chin | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.92 per share. | 31 Mar 2020 | 555 | 7,157 (0%) | 0% | 12.9 | 7,171 | Common Stock |
| Linda Marsh | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2020 | 62,500 | 0 | - | - | Stock Option (right to buy) | |
| Linda Marsh | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.00 per share. | 04 Mar 2020 | 62,500 | 62,500 (0%) | 0% | 10 | 625,000 | Common Stock |
| Linda Marsh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2020 | 62,500 | 62,500 | - | - | Stock Option (right to buy) | |
| Linda Marsh | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Mar 2020 | 62,500 | 0 | - | - | Stock Option (right to buy) | |
| Mitchell W. Kitayama | Director | Other type of transaction at price $ 0.00 per share. | 05 Feb 2020 | 2,048 | 18,500 | - | - | Stock Option (right to buy) | |
| Mitchell W. Kitayama | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2020 | 3,409 | 21,909 | - | - | Stock Option (right to buy) | |
| David G. Schmidt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2020 | 3,409 | 101,909 | - | - | Stock Option (right to buy) | |
| David G. Schmidt | Director | Other type of transaction at price $ 0.00 per share. | 05 Feb 2020 | 2,048 | 98,500 | - | - | Stock Option (right to buy) | |
| Mark Fawcett | Director | Other type of transaction at price $ 0.00 per share. | 05 Feb 2020 | 2,048 | 53,500 | - | - | Stock Option (right to buy) | |
| Mark Fawcett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2020 | 3,409 | 56,909 | - | - | Stock Option (right to buy) | |
| Hing Ang | Chief Operating Officer | Other type of transaction at price $ 0.00 per share. | 05 Feb 2020 | 3,674 | 37,593 (0%) | 0% | 0 | Common Stock | |
| Hing Ang | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2020 | 3,666 | 41,259 (0%) | 0% | 0 | Common Stock | |
| Albert Young | Chief Administrative Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2020 | 1,880 | 966,296 (1%) | 0% | 0 | Common Stock | |
| Albert Young | Chief Administrative Officer | Other type of transaction at price $ 0.00 per share. | 05 Feb 2020 | 1,885 | 916,446 (1%) | 0% | 0 | Common Stock | |
| Eric Chin | CFO & Corporate Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2020 | 4,073 | 7,712 (0%) | 0% | 0 | Common Stock | |
| Eric Chin | CFO & Corporate Secretary | Other type of transaction at price $ 0.00 per share. | 05 Feb 2020 | 4,083 | 3,639 (0%) | 0% | 0 | Common Stock | |
| John Chiang | Director | Other type of transaction at price $ 0.00 per share. | 05 Feb 2020 | 900 | 11,000 | - | - | Stock Option (right to buy) | |
| John Chiang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2020 | 1,515 | 12,515 | - | - | Stock Option (right to buy) | |
| Thomas S. Lam | Director, President and Co-CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2019 | 28,046 | 28,046 | - | - | Stock Option (right to buy) | |
| Thomas S. Lam | Director, President and Co-CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2019 | 61,343 | 61,343 (0%) | 0% | 0 | Common Stock | |
| Kenneth Sim | Director, Executive Chairman and Co-CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2019 | 28,046 | 28,046 | - | - | Stock Option (right to buy) | |
| Kenneth Sim | Director, Executive Chairman and Co-CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2019 | 61,343 | 61,343 (0%) | 0% | 0 | Common Stock | |
| Thomas S. Lam | Director, President and Co-CEO | Other type of transaction at price $ 0.00 per share. | 27 Dec 2019 | 58,883 | 0 (0%) | 0% | 0 | Common Stock | |
| Thomas S. Lam | Director, President and Co-CEO | Other type of transaction at price $ 0.00 per share. | 27 Dec 2019 | 39,189 | 0 | - | - | Stock Option (right to buy) | |
| Kenneth Sim | Director, Executive Chairman and Co-CEO | Other type of transaction at price $ 0.00 per share. | 27 Dec 2019 | 39,189 | 0 | - | - | Stock Option (right to buy) | |
| Kenneth Sim | Director, Executive Chairman and Co-CEO | Other type of transaction at price $ 0.00 per share. | 27 Dec 2019 | 58,883 | 0 (0%) | 0% | 0 | Common Stock | |
| Thomas S. Lam | Director, President and Co-CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2019 | 93,450 | 17,158,389 (32%) | 0% | 0 | Common Stock | |
| Thomas S. Lam | Director, President and Co-CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2019 | 86,874 | 1,830,497 (3%) | 0% | 0 | Common Stock | |
| Kenneth Sim | Director, Executive Chairman and Co-CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2019 | 93,450 | 17,158,389 (32%) | 0% | 0 | Common Stock | |
| Kenneth Sim | Director, Executive Chairman and Co-CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2019 | 86,878 | 1,824,439 (3%) | 0% | 0 | Common Stock | |
| Albert Young | Chief Administrative Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2019 | 47,970 | 966,301 (1%) | 0% | 0 | Common Stock | |
| Albert Young | Chief Administrative Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2019 | 93,450 | 17,158,389 (32%) | 0% | 0 | Common Stock | |
| Michael F. Eng | None | Purchase of securities on an exchange or from another person at price $ 18.48 per share. | 04 Dec 2019 | 1,890 | 4,890 (0%) | 0% | 18.5 | 34,927 | Common Stock |
| Hing Ang | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Nov 2019 | 3,674 | 41,267 (0%) | 0% | 0 | Common Stock | |
| Albert Young | Chief Administrative Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Nov 2019 | 1,885 | 918,331 (1%) | 0% | 0 | Common Stock | |
| Eric Chin | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Nov 2019 | 4,083 | 7,722 (0%) | 0% | 0 | Common Stock | |
| Mitchell W. Kitayama | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Nov 2019 | 2,048 | 20,548 | - | - | Stock Options | |
| David G. Schmidt | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Nov 2019 | 2,048 | 100,548 | - | - | Stock Options | |
| Mark Fawcett | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Nov 2019 | 2,048 | 55,548 | - | - | Stock Options | |
| John Chiang | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Nov 2019 | 900 | 11,900 | - | - | Stock Options | |
| Thomas S. Lam | Director, President and Co-CEO | Purchase of securities on an exchange or from another person at price $ 14.84 per share. | 14 Nov 2019 | 10,000 | 1,743,623 (3%) | 0% | 14.8 | 148,400 | Common Stock |
| Kenneth Sim | Director, Executive Chairman and Co-CEO | Purchase of securities on an exchange or from another person at price $ 14.67 per share. | 14 Nov 2019 | 10,000 | 1,737,561 (3%) | 0% | 14.7 | 146,700 | Common Stock |
| Mitchell W. Kitayama | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Oct 2019 | 11,000 | 18,500 | - | - | Stock Options | |
| Ernest A. Bates | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Oct 2019 | 11,000 | 18,500 | - | - | Stock Options | |
| Li Yu | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Oct 2019 | 11,000 | 18,500 | - | - | Stock Options | |
| David G. Schmidt | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Oct 2019 | 11,000 | 98,500 | - | - | Stock Options | |
| Mark Fawcett | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Oct 2019 | 11,000 | 53,500 | - | - | Stock Options | |
| Michael F. Eng | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Oct 2019 | 11,000 | 18,500 | - | - | Stock Options | |
| Linda Marsh | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Oct 2019 | 11,000 | 73,500 | - | - | Stock Options | |
| John Chiang | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Oct 2019 | 11,000 | 11,000 | - | - | Stock Options | |
| Kenneth Sim | Director, Executive Chairman and Co-CEO | Purchase of securities on an exchange or from another person at price $ 15.55 per share. | 08 Oct 2019 | 5,000 | 1,727,561 (3%) | 0% | 15.6 | 77,750 | Common Stock |
| Michael F. Eng | None | Purchase of securities on an exchange or from another person at price $ 20.28 per share. | 12 Sep 2019 | 2,000 | 3,000 (0%) | 0% | 20.3 | 40,560 | Common Stock |
| Adrian Vazquez | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 19.77 per share. | 11 Sep 2019 | 27,350 | 520,941 (0%) | 0% | 19.8 | 540,710 | Common Stock |
| Adrian Vazquez | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 20.14 per share. | 11 Sep 2019 | 13,746 | 548,291 (1%) | 0% | 20.1 | 276,844 | Common Stock |
| Adrian Vazquez | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 20.14 per share. | 11 Sep 2019 | 43,704 | 562,037 (1%) | 0% | 20.1 | 880,199 | Common Stock |
| Thomas S. Lam | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Sep 2019 | 15,015,015 | 16,790,575 (31%) | 41% | - | Common Stock | |
| Kenneth Sim | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Sep 2019 | 15,015,015 | 16,790,575 (31%) | 41% | - | Common Stock | |
| Albert Young | Co-Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Sep 2019 | 15,015,015 | 16,750,575 (31%) | 41% | - | Common Stock | |
| Michael F. Eng | None | Purchase of securities on an exchange or from another person at price $ 15.97 per share. | 19 Aug 2019 | 1,000 | 1,000 (0%) | 0% | 16.0 | 15,970 | Common Stock |
| Thomas S. Lam | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 15.57 per share. | 14 Aug 2019 | 4,000 | 1,668,740 (3%) | 0% | 15.6 | 62,280 | Common Stock |
| Thomas S. Lam | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 16.19 per share. | 14 Aug 2019 | 6,000 | 1,674,740 (3%) | 0% | 16.2 | 97,140 | Common Stock |
| Thomas S. Lam | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 16.85 per share. | 14 Aug 2019 | 7,200 | 1,664,740 (3%) | 0% | 16.9 | 121,320 | Common Stock |
| Kenneth Sim | Director, Executive Chairman | Purchase of securities on an exchange or from another person at price $ 16.23 per share. | 14 Aug 2019 | 2,000 | 1,659,678 (3%) | 0% | 16.2 | 32,460 | Common Stock |
| Kenneth Sim | Director, Executive Chairman | Purchase of securities on an exchange or from another person at price $ 15.25 per share. | 14 Aug 2019 | 1,500 | 1,661,178 (3%) | 0% | 15.3 | 22,875 | Common Stock |
| Kenneth Sim | Director, Executive Chairman | Purchase of securities on an exchange or from another person at price $ 16.35 per share. | 14 Aug 2019 | 563 | 1,663,678 (3%) | 0% | 16.3 | 9,205 | Common Stock |
| Kenneth Sim | Director, Executive Chairman | Purchase of securities on an exchange or from another person at price $ 16.35 per share. | 14 Aug 2019 | 437 | 1,663,115 (3%) | 0% | 16.4 | 7,145 | Common Stock |
| Kenneth Sim | Director, Executive Chairman | Purchase of securities on an exchange or from another person at price $ 16.25 per share. | 14 Aug 2019 | 1,500 | 1,662,678 (3%) | 0% | 16.3 | 24,375 | Common Stock |
| Albert Young | Co-Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 15.01 per share. | 14 Aug 2019 | 5,000 | 916,446 (1%) | 0% | 15.0 | 75,050 | Common Stock |
| John Chiang | None | Purchase of securities on an exchange or from another person at price $ 16.31 per share. | 14 Jun 2019 | 100 | 100 (0%) | 0% | 16.3 | 1,631 | Common Stock |
| Eric Chin | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 14.72 per share. | 12 Jun 2019 | 2,040 | 3,639 (0%) | 0% | 14.7 | 30,029 | Common Stock |
| Mark Fawcett | None | Purchase of securities on an exchange or from another person at price $ 14.13 per share. | 11 Jun 2019 | 10,000 | 10,000 (0%) | 0% | 14.1 | 141,300 | Common Stock |
| Thomas S. Lam | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 14.64 per share. | 11 Jun 2019 | 6,900 | 1,657,540 (3%) | 0% | 14.6 | 101,016 | Common Stock |
| Kenneth Sim | Director, Executive Chairman | Purchase of securities on an exchange or from another person at price $ 14.45 per share. | 11 Jun 2019 | 1,300 | 1,657,678 (3%) | 0% | 14.5 | 18,785 | Common Stock |
| Kenneth Sim | Director, Executive Chairman | Purchase of securities on an exchange or from another person at price $ 14.51 per share. | 11 Jun 2019 | 5,696 | 1,656,378 (3%) | 0% | 14.5 | 82,649 | Common Stock |
| Adrian Vazquez | Co-Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 16.01 per share. | 03 Jun 2019 | 38,051 | 605,741 (1%) | 0% | 16.0 | 609,056 | Common Stock |
| Adrian Vazquez | Co-Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 16.64 per share. | 03 Jun 2019 | 46,949 | 643,792 (1%) | 0% | 16.6 | 781,114 | Common Stock |
| Eric Chin | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2019 | 1,599 | 1,599 (0%) | 0% | 0 | Common Stock | |
| Mitchell W. Kitayama | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2019 | 7,500 | 7,500 | - | - | Stock Options | |
| Ernest A. Bates | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2019 | 7,500 | 7,500 | - | - | Stock Options | |
| Li Yu | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2019 | 7,500 | 7,500 | - | - | Stock Options | |
| David G. Schmidt | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2019 | 7,500 | 7,500 | - | - | Stock Options | |
| Mark Fawcett | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2019 | 7,500 | 7,500 | - | - | Stock Options | |
| Michael F. Eng | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2019 | 7,500 | 7,500 | - | - | Stock Options | |
| Thomas S. Lam | Director, Co-Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2018 | 86,876 | 1,650,640 (4%) | 0% | 0 | Common Stock | |
| Thomas S. Lam | Director, Co-Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2018 | 93,451 | 1,775,560 (5%) | 0% | 0 | Common Stock | |
| Kenneth Sim | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2018 | 86,878 | 1,650,682 (4%) | 0% | 0 | Common Stock | |
| Kenneth Sim | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2018 | 93,451 | 1,775,560 (5%) | 0% | 0 | Common Stock | |
| Albert Young | Co-Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2018 | 93,451 | 1,775,560 (5%) | 0% | 0 | Common Stock | |
| Albert Young | Co-Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2018 | 47,971 | 911,446 (2%) | 0% | 0 | Common Stock | |
| Warren Hosseinion | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 17.31 per share. | 26 Nov 2018 | 30,000 | 559,438 (1%) | 0% | 17.3 | 519,300 | Common Stock |
| Warren Hosseinion | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 17.91 per share. | 26 Nov 2018 | 20,000 | 589,438 (1%) | 0% | 17.9 | 358,200 | Common Stock |
| Warren Hosseinion | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 17.07 per share. | 21 Nov 2018 | 20,000 | 609,438 (1%) | 0% | 17.1 | 341,400 | Common Stock |
| Warren Hosseinion | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 16.21 per share. | 21 Nov 2018 | 30,000 | 629,438 (1%) | 0% | 16.2 | 486,300 | Common Stock |
| Warren Hosseinion | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 18.97 per share. | 19 Nov 2018 | 20,000 | 679,438 (1%) | 0% | 19.0 | 379,400 | Common Stock |
| Warren Hosseinion | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 17.58 per share. | 19 Nov 2018 | 20,000 | 659,438 (1%) | 0% | 17.6 | 351,600 | Common Stock |
| Adrian Vazquez | Co-Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 18.56 per share. | 19 Nov 2018 | 77,868 | 834,470 (2%) | 0% | 18.6 | 1,445,215 | Common Stock |
| Adrian Vazquez | Co-Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 16.51 per share. | 19 Nov 2018 | 75,000 | 690,741 (2%) | 0% | 16.5 | 1,238,100 | Common Stock |
| Adrian Vazquez | Co-Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 17.55 per share. | 19 Nov 2018 | 68,729 | 765,741 (2%) | 0% | 17.6 | 1,206,435 | Common Stock |
| Adrian Vazquez | Co-Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 16.01 per share. | 07 Sep 2018 | 7,886 | 912,338 (2%) | 0% | 16.0 | 126,255 | Common Stock |
| Adrian Vazquez | Co-Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 15.02 per share. | 07 Sep 2018 | 25,688 | 920,224 (2%) | 0% | 15.0 | 385,834 | Common Stock |
| Warren Hosseinion | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 16.03 per share. | 29 Aug 2018 | 15,000 | 707,338 (2%) | 0% | 16.0 | 240,450 | Common Stock |
| Warren Hosseinion | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 15.76 per share. | 29 Aug 2018 | 7,900 | 699,438 (2%) | 0% | 15.8 | 124,504 | Common Stock |
| Warren Hosseinion | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 17.35 per share. | 27 Aug 2018 | 15,000 | 737,338 (2%) | 0% | 17.4 | 260,250 | Common Stock |
| Warren Hosseinion | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 16.65 per share. | 27 Aug 2018 | 15,000 | 722,338 (2%) | 0% | 16.7 | 249,750 | Common Stock |
| Adrian Vazquez | Co-Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 17.35 per share. | 27 Aug 2018 | 25,000 | 945,912 (2%) | 0% | 17.4 | 433,750 | Common Stock |
| Adrian Vazquez | Co-Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Aug 2018 | 18,574 | 4,826 | - | - | Stock Option (right to buy) | |
| Adrian Vazquez | Co-Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Aug 2018 | 10,000 | 23,400 | - | - | Stock Option (right to buy) | |
| Adrian Vazquez | Co-Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Aug 2018 | 30,000 | 33,400 | - | - | Stock Option (right to buy) | |
| Adrian Vazquez | Co-Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.37 per share. | 24 Aug 2018 | 18,574 | 970,912 (2%) | 0% | 6.4 | 118,316 | Common Stock |
| Adrian Vazquez | Co-Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.00 per share. | 24 Aug 2018 | 10,000 | 952,338 (2%) | 0% | 10 | 100,000 | Common Stock |
| Adrian Vazquez | Co-Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.50 per share. | 24 Aug 2018 | 30,000 | 942,338 (2%) | 0% | 1.5 | 45,000 | Common Stock |
| Warren Hosseinion | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 16.47 per share. | 23 Aug 2018 | 15,000 | 752,338 (2%) | 0% | 16.5 | 247,050 | Common Stock |
| Warren Hosseinion | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 15.97 per share. | 23 Aug 2018 | 18,000 | 767,338 (2%) | 0% | 16.0 | 287,460 | Common Stock |
| Warren Hosseinion | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 16.73 per share. | 21 Aug 2018 | 15,000 | 800,338 (2%) | 0% | 16.7 | 250,950 | Common Stock |
| Warren Hosseinion | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 16.32 per share. | 21 Aug 2018 | 15,000 | 785,338 (2%) | 0% | 16.3 | 244,800 | Common Stock |
| Warren Hosseinion | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 18.51 per share. | 17 Aug 2018 | 10,000 | 827,338 (2%) | 0% | 18.5 | 185,100 | Common Stock |
| Warren Hosseinion | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 17.75 per share. | 17 Aug 2018 | 12,000 | 815,338 (2%) | 0% | 17.8 | 213,000 | Common Stock |
| Gary M. Augusta | None | Sale of securities on an exchange or to another person at price $ 18.71 per share. | 17 Aug 2018 | 12,948 | 152,997 (0%) | 0% | 18.7 | 242,218 | Common Stock |
| Warren Hosseinion | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 16.35 per share. | 14 Jun 2018 | 20,000 | 837,338 (2%) | 0% | 16.4 | 327,000 | Common Stock |
| Warren Hosseinion | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 15.44 per share. | 12 Jun 2018 | 13,000 | 872,338 (2%) | 0% | 15.4 | 200,720 | Common Stock |
| Warren Hosseinion | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 15.77 per share. | 12 Jun 2018 | 15,000 | 857,338 (2%) | 0% | 15.8 | 236,550 | Common Stock |
| Warren Hosseinion | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 15.44 per share. | 08 Jun 2018 | 12,000 | 885,338 (2%) | 0% | 15.4 | 185,280 | Common Stock |
| Warren Hosseinion | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 14.73 per share. | 08 Jun 2018 | 8,000 | 897,338 (2%) | 0% | 14.7 | 117,840 | Common Stock |
| Warren Hosseinion | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 14.20 per share. | 06 Jun 2018 | 14,535 | 905,338 (2%) | 0% | 14.2 | 206,397 | Common Stock |
| Warren Hosseinion | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 14.70 per share. | 06 Jun 2018 | 13,876 | 919,873 (2%) | 0% | 14.7 | 203,977 | Common Stock |
| Warren Hosseinion | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 14.85 per share. | 04 Jun 2018 | 13,876 | 933,749 (2%) | 0% | 14.9 | 206,059 | Common Stock |
| Warren Hosseinion | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 14.78 per share. | 04 Jun 2018 | 13,876 | 947,625 (2%) | 0% | 14.8 | 205,087 | Common Stock |
| Warren Hosseinion | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 14.37 per share. | 31 May 2018 | 11,876 | 961,501 (2%) | 0% | 14.4 | 170,658 | Common Stock |
| Warren Hosseinion | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 13.63 per share. | 31 May 2018 | 9,476 | 973,377 (2%) | 0% | 13.6 | 129,158 | Common Stock |
| Warren Hosseinion | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 13.28 per share. | 29 May 2018 | 5,876 | 982,853 (2%) | 0% | 13.3 | 78,033 | Common Stock |
| Warren Hosseinion | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 13.52 per share. | 29 May 2018 | 5,876 | 988,729 (2%) | 0% | 13.5 | 79,444 | Common Stock |
| Warren Hosseinion | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 13.70 per share. | 24 May 2018 | 5,876 | 994,605 (2%) | 0% | 13.7 | 80,501 | Common Stock |
| Warren Hosseinion | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 14.19 per share. | 24 May 2018 | 5,876 | 1,000,481 (3%) | 0% | 14.2 | 83,380 | Common Stock |
| Warren Hosseinion | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 14.69 per share. | 22 May 2018 | 5,876 | 1,006,357 (3%) | 0% | 14.7 | 86,318 | Common Stock |
| Warren Hosseinion | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 15.39 per share. | 22 May 2018 | 5,876 | 1,012,233 (3%) | 0% | 15.4 | 90,432 | Common Stock |
| Warren Hosseinion | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 15.90 per share. | 18 May 2018 | 5,876 | 1,023,985 (3%) | 0% | 15.9 | 93,428 | Common Stock |
| Warren Hosseinion | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 15.66 per share. | 18 May 2018 | 5,876 | 1,018,109 (3%) | 0% | 15.7 | 92,018 | Common Stock |
| Hing Ang | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2018 | 37,593 | 37,593 (0%) | 0% | 0 | Common Stock | |
| Warren Hosseinion | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2018 | 22,476 | 71,024 | - | - | Stock Option | |
| Warren Hosseinion | Director, Co-Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.90 per share. | 15 Jan 2018 | 4,953 | 1,029,861 (3%) | 0% | 28.9 | 143,142 | Common Stock |
| Warren Hosseinion | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.37 per share. | 15 Jan 2018 | 22,476 | 1,034,814 (3%) | 0% | 6.4 | 143,172 | Common Stock |
| Mihir Shah | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.50 per share. | 15 Jan 2018 | 23,610 | 23,610 (0%) | 0% | 4.5 | 106,245 | Common Stock |
| Mihir Shah | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2018 | 23,610 | 26,390 | - | - | Stock Option | |
| Mihir Shah | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.90 per share. | 15 Jan 2018 | 3,678 | 19,932 (0%) | 0% | 28.9 | 106,294 | Common Stock |
| Thomas S. Lam | Director, Co-Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 08 Dec 2017 | 52,263 | 52,262 | - | - | Warrants to purchase Common Stock | |
| Thomas S. Lam | Director, Co-Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 08 Dec 2017 | 1,682,109 | 1,682,109 (5%) | 5% | 0 | Common Stock | |
| Thomas S. Lam | Director, Co-Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 08 Dec 2017 | 1,664,054 | 1,664,054 (5%) | 5% | 0 | Common Stock | |
| Thomas S. Lam | Director, Co-Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 08 Dec 2017 | 1,563,763 | 1,563,763 (4%) | 4% | 0 | Common Stock | |
| Thomas S. Lam | Director, Co-Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 08 Dec 2017 | 68,317 | 68,317 | - | - | Warrants to purchase Common Stock | |
| Thomas S. Lam | Director, Co-Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 08 Dec 2017 | 34,159 | 34,158 | - | - | Warrants to purchase Common Stock | |
| Thomas S. Lam | Director, Co-Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 08 Dec 2017 | 55,337 | 55,337 | - | - | Warrants to purchase Common Stock | |
| Warren Hosseinion | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2017 | 23,363 | 23,363 | - | - | Stock Option (right to buy) | |
| Warren Hosseinion | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2017 | 6,637 | 6,637 | - | - | Stock Option (right to buy) | |
| Adrian Vazquez | Chief Medical Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2017 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Gary M. Augusta | Director, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2017 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Mihir Shah | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2017 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Mihir Shah | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Nov 2016 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Warren Hosseinion | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2016 | 93,500 | 93,500 | - | - | Stock Option (right to buy) | |
| Suresh T. Nihalani | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2016 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Suresh T. Nihalani | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2016 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Adrian Vazquez | Chief Medical Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2016 | 23,400 | 23,400 | - | - | Stock Option (right to buy) | |
| Gary M. Augusta | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2016 | 93,500 | 93,500 | - | - | Stock Option (right to buy) | |
| David Schmidt | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2016 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| David Schmidt | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2016 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Mark Fawcett | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2016 | 20,000 | 20,000 | - | - | Common Stock | |
| Mark Fawcett | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2016 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Edward Schreck | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2016 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Edward Schreck | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2016 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Thomas S. Lam | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 30 Mar 2016 | 555,555 | 555,555 | - | - | Series B Preferred Stock | |
| Thomas S. Lam | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 30 Mar 2016 | 555,555 | 1,666,666 | - | - | Warrants to purchase Common Stock | |
| Mitch Creem | Director, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2015 | 500 | 500 | - | - | Option | |
| Mitch Creem | Director, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2015 | 500 | 500 | - | - | Option | |
| Mitch Creem | Director, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2015 | 500 | 500 | - | - | Option | |
| Gary M. Augusta | Director, Executive Chairman | Other type of transaction at price $ 0.00 per share. | 30 Apr 2013 | 100,000 | 1,659,457 | - | - | Common Stock | |
| Noel DeWinter | Chief Financial Officer | 31 Jan 2010 | 250,000 | 250,000 | - | - | Common Stock, par value $.001 per share | ||
| Suresh T. Nihalani | None | 31 Jan 2010 | 400,000 | 400,000 | - | - | Common Stock, par value $.001 per share | ||
| Bradley S. Shepherd | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 20 May 2005 | 1,800,000 | 10,200,000 | - | - | Common Stock |